ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 680

Development and Preliminary Validation of the Computed Tomography Sacroiliac Structural Score for Assessment of Structural Lesions in Axial Spondyloarthritis

Walter Maksymowych1, Marie Raynal2, Damien Loeuille3, Maria Antonietta D'Agostino4, Joel Paschke5 and Robert G Lambert6, 1Medicine, University of Alberta, Edmonton, AB, Canada, 2Rheumatology, CHRU Nancy, Nancy, France, 3Rheumatology, CHRU Vandoeuvre les Nancy, Nancy, France, 4Rheumatology, Versailles-Saint Quentin en Yvelines University, Boulogne-Billancourt, France, 5CaRE Arthritis, Edmonton, AB, Canada, 6Radiology, University of Alberta, Edmonton, AB, Canada

Meeting: 2016 ACR/ARHP Annual Meeting

Date of first publication: September 28, 2016

Keywords: computed tomography (CT) and spondylarthritis, Validity

  • Tweet
  • Email
  • Print
Session Information

Date: Sunday, November 13, 2016

Title: Spondylarthropathies and Psoriatic Arthritis – Clinical Aspects and Treatment - Poster I: Axial and Peripheral Spondyloarthritis – Clinical Aspects, Imaging and Treatment

Session Type: ACR Poster Session A

Session Time: 9:00AM-11:00AM

Background/Purpose: Computed tomography (CT) is considered the imaging benchmark for the assessment of certain structural lesions in the sacroiliac joints (SIJ) of patients with axial spondyloarthritis (axSpA). Availability of low dose radiation techniques may lead to more widespread use, potentially as a structural endpoint in clinical trials research. We aimed to validate a new CT-based scoring method, the CT Sacroiliac Structural Score (CT-SSS), for assessing structural lesions in the SIJ.

Methods:  CT scans of the SIJ from 44 patients (26 females, mean age 49.4 years, mean symptom duration 9.1 years) were reconstructed in the semicoronal plane parallel to the superior border of the sacrum and scoring of lesions was confined to this plane. Structural lesions were scored in consecutive slices in SIJ quadrants (erosion, sclerosis) or SIJ halves (ankylosis) on a dichotomous basis (present/absent) using the same anatomical principles as developed for the SPARCC MRI SIJ inflammation and structural scores. The most anterior slice is defined as visible joint >1cm vertical height and when <3 cm is defined as having only upper iliac and sacral quadrants. A visible joint >3cm vertical height is defined as having 4 quadrants. At the posterior aspect of the SIJ, there is a natural separation of iliac and sacral cortical bone by structures in the ligamentary portion. Scoring is terminated when <1cm of iliac and sacral bone is appositional. Two readers independently scored CT scans without a prior calibration exercise and using direct online data entry onto a schematic of the SIJ. Reliability was assessed by kappa statistics, intra-class correlation coefficient (ICC), and Bland-Altman limits of agreement.

Results: Scoring was feasible (5-10 minutes per scan) and both ankylosis (ICC=0.95) and erosion (ICC=0.81) were scored to a high degree of reliability (Table). Sclerosis was less reliably scored (ICC=0.39).  Presence/absence of ankylosis was reliably detected irrespective of whether this was based on a single slice (κ=0.77) or 3 consecutive slices (κ=0.81). Reliable detection (presence/absence) was lower for erosion (κ=0.50 for 1 or 3 slices) and sclerosis (κ=0.44 and 0.48 for 1 and 3 slices, respectively). Bland-Altman graphs illustrate reliability across the range of scores for ankylosis and erosion (Figure).

Conclusion: The CT-SSS method is feasible and reliable for scoring ankylosis and erosion with minimal calibration. Sclerosis requires further standardization and calibration.

Mean (SD) score

Median (IQR) score

R1

R2

R1

R2

ICC

95% L of A

Erosion

4.4 (9.7)

6.5 (11.5)

0 (25.5)

0 (21)

0.95

-10.7, 13.5

Ankylosis

7.5 (14.1)

6 (13.6)

0 (12)

0 (12)

0.81

-16.2, 12.2

Sclerosis

6.6 (14.4)

7.4 (18.2)

0 (20)

0   (24.5)

0.39

-34.5, 33.0

IQR  interquartile range          L of A   Limits of Agreement                   

Table. Descriptive and Reliability data for CT-SSS score.

Figure.


Disclosure: W. Maksymowych, Abbvie, 2,Janssen Pharmaceutica Product, L.P., 2,Pfizer Inc, 2,Sanofi-Aventis Pharmaceutical, 2,Abbvie, 5,Boehringer Ingelheim, 5,Eli Lilly and Company, 5,Celgene, 5,Novartis Pharmaceutical Corporation, 5,Pfizer Inc, 5,Sanofi-Aventis Pharmaceutical, 5,UCB, 5,Amgen, 5; M. Raynal, None; D. Loeuille, None; M. A. D'Agostino, None; J. Paschke, None; R. G. Lambert, BioClinica, 5,Abbvie, 8.

To cite this abstract in AMA style:

Maksymowych W, Raynal M, Loeuille D, D'Agostino MA, Paschke J, Lambert RG. Development and Preliminary Validation of the Computed Tomography Sacroiliac Structural Score for Assessment of Structural Lesions in Axial Spondyloarthritis [abstract]. Arthritis Rheumatol. 2016; 68 (suppl 10). https://acrabstracts.org/abstract/development-and-preliminary-validation-of-the-computed-tomography-sacroiliac-structural-score-for-assessment-of-structural-lesions-in-axial-spondyloarthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2016 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/development-and-preliminary-validation-of-the-computed-tomography-sacroiliac-structural-score-for-assessment-of-structural-lesions-in-axial-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology